2014
DOI: 10.3109/01443615.2014.925857
|View full text |Cite
|
Sign up to set email alerts
|

X-linked ichthyosis: Differential diagnosis of low maternal oestriol level

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…Excessive accumulation of cholesterol sulfate increases epidermal cell adhesion and stability, resulting in hyperkeratosis and formation of scales. Previous studies have demonstrated a low serum free estriol level in the pregnant woman carrying a fetus with XLI, suggesting that serological test may be indicative of XLI . In this study, the pregnant women from two pedigrees were admitted due to high‐risk screening results in the second trimester, and the serum free estriol had a 0.121 multiple of the median in the pregnant woman from Pedigree 1 and a 0.14 multiple of the median in the pregnant woman from Pedigree 2, both of which were lower than the reference range (0.5‐2 multiples of the median).…”
Section: Discussionmentioning
confidence: 71%
“…Excessive accumulation of cholesterol sulfate increases epidermal cell adhesion and stability, resulting in hyperkeratosis and formation of scales. Previous studies have demonstrated a low serum free estriol level in the pregnant woman carrying a fetus with XLI, suggesting that serological test may be indicative of XLI . In this study, the pregnant women from two pedigrees were admitted due to high‐risk screening results in the second trimester, and the serum free estriol had a 0.121 multiple of the median in the pregnant woman from Pedigree 1 and a 0.14 multiple of the median in the pregnant woman from Pedigree 2, both of which were lower than the reference range (0.5‐2 multiples of the median).…”
Section: Discussionmentioning
confidence: 71%
“…4 Further uses of maternal serum screening include screening for neural tube defects with increased AFP levels, and for various fetal and maternal disorders with low maternal estriol levels. 5,6 Noninvasive prenatal testing (NIPT) was first introduced in 2011 7 and has become widely used in the past decade. Owing to its high sensitivity and specificity for the detection of Down syndrome, in conjunction with higher positive predictive values compared with conventional maternal serum screening, 8 it has been suggested that NIPT can replace invasive testing in cases of abnormal maternal serum screening.…”
Section: Resultsmentioning
confidence: 99%
“…4 Further uses of maternal serum screening include screening for neural tube defects with increased AFP levels, and for various fetal and maternal disorders with low maternal estriol levels. 5,6…”
mentioning
confidence: 99%